Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells

Por Meira, D D, de Almeida, V H, Mororó, J S, Nóbrega, I, Bardella, L, Silva, R L A, Albano, R M, Ferreira, C G
Publicado em 2009